leisure time -WSS

leisure time

author：Wikipedia 2025-09-30 22:41:50 - browse：93278

STAT's Damian Garde speaks with Mikael Dolsten and Mathai Mammen, in New York on March 21, 2024 — From left to right, STAT's Damian Garde; Mikael Dolsten, chief scientific officer of Pfizer research and development; and Rose Loughlin, Moderna’s senior vice president of early research and development, discuss the future of pharma at the STAT 2024 Breakthrough Summit East. STAT

Drug development is more of a sprint than a marathon these days, thanks to more and better ways to target underlying biology and a more nuanced interpretation of precision medicine, three biotech leaders said at the STAT Breakthrough Summit East in New York Thursday.

“We used to say, well, you may spend five years in the research phase, another five in development. Now I see a project that takes one year of research, from an idea to studies,” said Mikael Dolsten, chief scientific officer and president of Pfizer research and development. “Time is life. You care about patients. And when the distance to run is long, it holds back the energy and the inspiration.”

Key to that success are transformative new technologies like messenger RNA, which powered vaccines developed by Pfizer with its partner BioNTech.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： As obesity drug market grows, telehealth companies court payers

hotspot

WSS

Naloxone nonprofit donates 200,000 doses after FDA approval

PBMs are inflating the cost of generic drugs. They must be reined in

The best solution to the drug shortages problem

Naloxone nonprofit donates 200,000 doses after FDA approval

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

California store owner shot dead in dispute over displaying Pride flag: Police

focus

leisure time

focus

ChatGPT in medicine: STAT answers readers' burning questions

CDC says it’s too soon to assess risk posed by Covid subvariant

At least 13 dead in Texas as scorching temps continue

As obesity drug market grows, telehealth companies court payers

Trump demands the U.S. pay no more for drugs than other countries … again

How the first Native Hawaiian psychiatrist helped diversify medicine

Wildfire smoke exposes gaps in outdoor worker protections

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

Malaria cases in Florida and Texas: Here’s what you need to know

National associations that represent hospice owe an apology

explore

Intellia plays down concerns on accidental germline transmission

Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn

Can U.S. cancer drug shortages be fixed?

Anavex keeps shifting the goalposts in its clinical trials

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

The best solution to the drug shortages problem

leisure time

hotspot

hotspot

knowledge